{"entity":{"type":"insider","cik":"0001378550","url":"/insider/0001378550","json_url":"/insider/0001378550.json","name":"Lowenthal Richard E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":73,"n_filings":23,"first":"2024-02-28","last":"2025-08-22","span_basis":"filed_date"},"name_variants":[{"name":"Lowenthal Richard E","source":"filing","n_filings":23,"first_seen":"2024-02-28","last_seen":"2025-08-22"}],"transactions":[{"id":5005488,"accession":"0001415889-25-022761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022761","line_url":"/filing/0001415889-25-022761#line-1","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":14.4869,"price_display":"14.49","price_state":"stated","total_value":724345.0,"total_display":"724,345.00","total_whole":"724,345","shares_owned_after":1196494.0,"shares_owned_after_display":"1,196,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":2102884,"accession":"0001415889-24-029851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029851","line_url":"/filing/0001415889-24-029851","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.671,"price_display":"11.67","price_state":"stated","total_value":1167100.0,"total_display":"1,167,100.00","total_whole":"1,167,100","shares_owned_after":1297447.0,"shares_owned_after_display":"1,297,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-19","scope":"insider","n_lines":2},{"id":2864601,"accession":"0001415889-24-029011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029011","line_url":"/filing/0001415889-24-029011","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":13.1642,"price_display":"13.16","price_state":"stated","total_value":1316420.0,"total_display":"1,316,420.00","total_whole":"1,316,420","shares_owned_after":1246494.0,"shares_owned_after_display":"1,246,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-11","scope":"insider","n_lines":2},{"id":2604975,"accession":"0001415889-24-027411","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-027411","line_url":"/filing/0001415889-24-027411","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":13.9496,"price_display":"13.95","price_state":"stated","total_value":1394960.0,"total_display":"1,394,960.00","total_whole":"1,394,960","shares_owned_after":1347447.0,"shares_owned_after_display":"1,347,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-21","scope":"insider","n_lines":2},{"id":2530962,"accession":"0001415889-24-026866","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-026866","line_url":"/filing/0001415889-24-026866","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":16.846424467,"price_display":"16.85","price_state":"stated","total_value":1684642.4467,"total_display":"1,684,642.45","total_whole":"1,684,642","shares_owned_after":1253375.0,"shares_owned_after_display":"1,253,375","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-14","scope":"insider","n_lines":4},{"id":2279881,"accession":"0001415889-24-025368","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-025368","line_url":"/filing/0001415889-24-025368","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":14.87595065,"price_display":"14.88","price_state":"stated","total_value":1487595.065,"total_display":"1,487,595.06","total_whole":"1,487,595","shares_owned_after":1298499.0,"shares_owned_after_display":"1,298,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider","n_lines":3},{"id":2448937,"accession":"0001415889-24-024980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-024980","line_url":"/filing/0001415889-24-024980","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":13.82775,"price_display":"13.83","price_state":"stated","total_value":1382775.0,"total_display":"1,382,775.00","total_whole":"1,382,775","shares_owned_after":1348499.0,"shares_owned_after_display":"1,348,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-08","filed_date":"2024-10-10","scope":"insider","n_lines":2},{"id":2279731,"accession":"0001415889-24-023709","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023709","line_url":"/filing/0001415889-24-023709","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":12.93205,"price_display":"12.93","price_state":"stated","total_value":1293205.0,"total_display":"1,293,205.00","total_whole":"1,293,205","shares_owned_after":1398499.0,"shares_owned_after_display":"1,398,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-19","scope":"insider","n_lines":2},{"id":3237565,"accession":"0001415889-24-023290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023290","line_url":"/filing/0001415889-24-023290","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.49775,"price_display":"11.50","price_state":"stated","total_value":1149775.0,"total_display":"1,149,775.00","total_whole":"1,149,775","shares_owned_after":1448499.0,"shares_owned_after_display":"1,448,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider","n_lines":2},{"id":2070457,"accession":"0001415889-24-021877","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-021877","line_url":"/filing/0001415889-24-021877","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":15.025865234,"price_display":"15.03","price_state":"stated","total_value":1502586.5234,"total_display":"1,502,586.52","total_whole":"1,502,587","shares_owned_after":1512283.0,"shares_owned_after_display":"1,512,283","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-21","scope":"insider","n_lines":6},{"id":2132468,"accession":"0001415889-24-021362","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-021362","line_url":"/filing/0001415889-24-021362","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":12.475549868,"price_display":"12.48","price_state":"stated","total_value":1247554.9868,"total_display":"1,247,554.99","total_whole":"1,247,555","shares_owned_after":1446494.0,"shares_owned_after_display":"1,446,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider","n_lines":4},{"id":2330468,"accession":"0001415889-24-019770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019770","line_url":"/filing/0001415889-24-019770","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.40295,"price_display":"11.40","price_state":"stated","total_value":1140295.0,"total_display":"1,140,295.00","total_whole":"1,140,295","shares_owned_after":1598499.0,"shares_owned_after_display":"1,598,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-18","scope":"insider","n_lines":2},{"id":2391895,"accession":"0001415889-24-019493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019493","line_url":"/filing/0001415889-24-019493","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":9.61725,"price_display":"9.62","price_state":"stated","total_value":961725.0,"total_display":"961,725.00","total_whole":"961,725","shares_owned_after":1496494.0,"shares_owned_after_display":"1,496,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-11","scope":"insider","n_lines":2},{"id":2530324,"accession":"0001415889-24-016678","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-016678","line_url":"/filing/0001415889-24-016678","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95862.0,"shares_display":"95,862","price_per_share":9.145049291690137,"price_display":"9.15","price_state":"stated","total_value":876662.7152,"total_display":"876,662.72","total_whole":"876,663","shares_owned_after":1698499.0,"shares_owned_after_display":"1,698,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-13","scope":"insider","n_lines":2},{"id":2530320,"accession":"0001415889-24-016678","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-016678","line_url":"/filing/0001415889-24-016678","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4138.0,"shares_display":"4,138","price_per_share":9.00290546157564,"price_display":"9.00","price_state":"stated","total_value":37254.0228,"total_display":"37,254.02","total_whole":"37,254","shares_owned_after":1594328.0,"shares_owned_after_display":"1,594,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-13","scope":"insider","n_lines":2},{"id":3085645,"accession":"0001415889-24-013387","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-013387","line_url":"/filing/0001415889-24-013387","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89096.0,"shares_display":"89,096","price_per_share":9.057900888928796,"price_display":"9.06","price_state":"stated","total_value":807022.7376,"total_display":"807,022.74","total_whole":"807,023","shares_owned_after":1597447.0,"shares_owned_after_display":"1,597,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-16","scope":"insider","n_lines":2},{"id":3085636,"accession":"0001415889-24-013387","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-013387","line_url":"/filing/0001415889-24-013387","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5147.0,"shares_display":"5,147","price_per_share":9.046961433844958,"price_display":"9.05","price_state":"stated","total_value":46564.7105,"total_display":"46,564.71","total_whole":"46,565","shares_owned_after":1792849.0,"shares_owned_after_display":"1,792,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-16","scope":"insider","n_lines":2},{"id":3085629,"accession":"0001415889-24-013387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-013387","line_url":"/filing/0001415889-24-013387","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5757.0,"shares_display":"5,757","price_per_share":9.007097516067397,"price_display":"9.01","price_state":"stated","total_value":51853.8604,"total_display":"51,853.86","total_whole":"51,854","shares_owned_after":1795615.0,"shares_owned_after_display":"1,795,615","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider","n_lines":2},{"id":2710251,"accession":"0001415889-24-012768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012768","line_url":"/filing/0001415889-24-012768","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":9.34365,"price_display":"9.34","price_state":"stated","total_value":934365.0,"total_display":"934,365.00","total_whole":"934,365","shares_owned_after":1798499.0,"shares_owned_after_display":"1,798,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-07","filed_date":"2024-05-09","scope":"insider","n_lines":2},{"id":2447452,"accession":"0001415889-24-011055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-011055","line_url":"/filing/0001415889-24-011055","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":9.28005,"price_display":"9.28","price_state":"stated","total_value":928005.0,"total_display":"928,005.00","total_whole":"928,005","shares_owned_after":1647447.0,"shares_owned_after_display":"1,647,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-16","filed_date":"2024-04-17","scope":"insider","n_lines":2},{"id":2952998,"accession":"0001415889-24-010659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010659","line_url":"/filing/0001415889-24-010659","is_derivative":false,"issuer_cik":"0001378550","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001378550","owner_cik":"0001378550","owner_name":"Lowenthal Richard E","owner_display_name":"Lowenthal Richard E","owner_url":"/insider/0001378550","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":9.27735,"price_display":"9.28","price_state":"stated","total_value":927735.0,"total_display":"927,735.00","total_whole":"927,735","shares_owned_after":1646494.0,"shares_owned_after_display":"1,646,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2024-04-09|2952994","ledger_fault":false,"count":{"value":73,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":73,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":73},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Director, Officer (PRESIDENT AND CEO), Ten percent owner","n_filings":23,"first_seen":"2024-02-28","last_seen":"2025-08-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378550","retrieved_at":"2026-08-26T06:36:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}